Mass spectrometry
-
Seer Proteograph Powers Groundbreaking 20,000-Sample Proteomics Study with Korea University, Aiming to Develop AI-Driven Cancer Diagnostics for Young Adults
Seer and Korea University are collaborating on a large-scale study to discover early cancer biomarkers using Seer’s Proteograph ONE Assay and mass spectrometry. This initiative aims to analyze 20,000 plasma samples to identify novel blood-based biomarkers for improved cancer diagnostics, particularly for young adults. The study, supported by the K-Health MIRAE initiative, utilizes AI-driven analytics, promising accelerated analysis, reduced costs, and the potential for earlier cancer detection and improved patient outcomes.
